Strong Dollar Remains Headache For Johnson & Johnson |
April 15, 2015 | April 2015 Bond Updates |
The continued climb of the U.S. dollar weighed heavily on pharmaceutical giant Johnson & Johnson's first quarter earnings reported Tuesday morning. |
View more at: http://www.forbes.com/sites/samanthasharf/2015/04/14/strong-dollar-remains-headache-for-johnson-johnson/ |
Related News |
|